SOPHiA GENETICS (SOPH) IPO Opens 3% Higher

Today's IPO for SOPHiA GENETICS SA, (NASDAQ: SOPH) opened for trading at $18.45 after pricing 13,000,000 ordinary shares at a price of $18 per share.

J.P. Morgan, Morgan Stanley, Cowen and Credit Suisse are acting as joint book-running managers for the offering.

SOPHiA GENETICS is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory and biopharma institutions globally.

You May Also Be Interested In

• CopperTech Metals launches IPO roadshow on NYSE at $16-$18 per share
• Cantor Equity Partners VII raises $250M in Nasdaq IPO
• Morgan Stanley Private Credit Fund Caps Redemptions At 5%